aluates Reports

$ 0.0

Automative

In-vitro Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-36B12093

Global In vitro Diagnostic Services Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

In-vitro Diagnostic Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-36B12093

Report

September 2024

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biorad

Dexcom

Nova Biomedical

Orasure

Pearl Pathways

Phenomenex

Qiagen NV

Roche Diagnostics

Siemens AG

Sysmex

ThermoFisher

In-vitro Diagnostic Services - Market Size

The global market for In-vitro Diagnostic Services was estimated to be worth US$ 64460 million in 2023 and is forecast to a readjusted size of US$ 87000 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030

In-vitro Diagnostic Services - Market

In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.

In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.

Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In-vitro Diagnostic Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of In-vitro Diagnostic Services by region & country, by Type, and by Application.

The In-vitro Diagnostic Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Diagnostic Services.

Market Segmentation

Scope of In-vitro Diagnostic Services - Market Report

Report Metric	Details
Report Name	In-vitro Diagnostic Services - Market
Forecasted market size in 2030	US$ 87000 million
CAGR	4.3%
Forecasted years	2024 - 2030
Segment by Type:	Infectious Testing Diabetes Testing Molecular Testing Tissue Testing
Segment by Application	Hospitals Point-Of-Care Testing Laboratories Academic Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche Diagnostics, Siemens, Sysmex, Thermofisher
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of In-vitro Diagnostic Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of In-vitro Diagnostic Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of In-vitro Diagnostic Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the In-vitro Diagnostic Services - Market size in 2030?

Ans: The In-vitro Diagnostic Services - Market size in 2030 will be US$ 87000 million.

Who are the main players in the In-vitro Diagnostic Services - Market report?

Ans: The main players in the In-vitro Diagnostic Services - Market are BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche Diagnostics, Siemens, Sysmex, Thermofisher

What are the Application segmentation covered in the In-vitro Diagnostic Services - Market report?

Ans: The Applications covered in the In-vitro Diagnostic Services - Market report are Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes

What are the Type segmentation covered in the In-vitro Diagnostic Services - Market report?

Ans: The Types covered in the In-vitro Diagnostic Services - Market report are Infectious Testing, Diabetes Testing, Molecular Testing, Tissue Testing

Recommended Reports

In-Vitro Diagnostics

Disease Diagnostics

Lab Diagnostic Services

1 Market Overview

1.1 In-vitro Diagnostic Services Product Introduction

1.2 Global In-vitro Diagnostic Services Market Size Forecast

1.3 In-vitro Diagnostic Services Market Trends & Drivers

1.3.1 In-vitro Diagnostic Services Industry Trends

1.3.2 In-vitro Diagnostic Services Market Drivers & Opportunity

1.3.3 In-vitro Diagnostic Services Market Challenges

1.3.4 In-vitro Diagnostic Services Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global In-vitro Diagnostic Services Players Revenue Ranking (2023)

2.2 Global In-vitro Diagnostic Services Revenue by Company (2019-2024)

2.3 Key Companies In-vitro Diagnostic Services Manufacturing Base Distribution and Headquarters

2.4 Key Companies In-vitro Diagnostic Services Product Offered

2.5 Key Companies Time to Begin Mass Production of In-vitro Diagnostic Services

2.6 In-vitro Diagnostic Services Market Competitive Analysis

2.6.1 In-vitro Diagnostic Services Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by In-vitro Diagnostic Services Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Infectious Testing

3.1.2 Diabetes Testing

3.1.3 Molecular Testing

3.1.4 Tissue Testing

3.2 Global In-vitro Diagnostic Services Sales Value by Type

3.2.1 Global In-vitro Diagnostic Services Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global In-vitro Diagnostic Services Sales Value, by Type (2019-2030)

3.2.3 Global In-vitro Diagnostic Services Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Point-Of-Care Testing

4.1.3 Laboratories

4.1.4 Academic Institutes

4.2 Global In-vitro Diagnostic Services Sales Value by Application

4.2.1 Global In-vitro Diagnostic Services Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global In-vitro Diagnostic Services Sales Value, by Application (2019-2030)

4.2.3 Global In-vitro Diagnostic Services Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global In-vitro Diagnostic Services Sales Value by Region

5.1.1 Global In-vitro Diagnostic Services Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global In-vitro Diagnostic Services Sales Value by Region (2019-2024)

5.1.3 Global In-vitro Diagnostic Services Sales Value by Region (2025-2030)

5.1.4 Global In-vitro Diagnostic Services Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America In-vitro Diagnostic Services Sales Value, 2019-2030

5.2.2 North America In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe In-vitro Diagnostic Services Sales Value, 2019-2030

5.3.2 Europe In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific In-vitro Diagnostic Services Sales Value, 2019-2030

5.4.2 Asia Pacific In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America In-vitro Diagnostic Services Sales Value, 2019-2030

5.5.2 South America In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa In-vitro Diagnostic Services Sales Value, 2019-2030

5.6.2 Middle East & Africa In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions In-vitro Diagnostic Services Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions In-vitro Diagnostic Services Sales Value

6.3 United States

6.3.1 United States In-vitro Diagnostic Services Sales Value, 2019-2030

6.3.2 United States In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

6.3.3 United States In-vitro Diagnostic Services Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe In-vitro Diagnostic Services Sales Value, 2019-2030

6.4.2 Europe In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe In-vitro Diagnostic Services Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China In-vitro Diagnostic Services Sales Value, 2019-2030

6.5.2 China In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

6.5.3 China In-vitro Diagnostic Services Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan In-vitro Diagnostic Services Sales Value, 2019-2030

6.6.2 Japan In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan In-vitro Diagnostic Services Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea In-vitro Diagnostic Services Sales Value, 2019-2030

6.7.2 South Korea In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea In-vitro Diagnostic Services Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia In-vitro Diagnostic Services Sales Value, 2019-2030

6.8.2 Southeast Asia In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia In-vitro Diagnostic Services Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India In-vitro Diagnostic Services Sales Value, 2019-2030

6.9.2 India In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

6.9.3 India In-vitro Diagnostic Services Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 BioRad

7.1.1 BioRad Profile

7.1.2 BioRad Main Business

7.1.3 BioRad In-vitro Diagnostic Services Products, Services and Solutions

7.1.4 BioRad In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.1.5 BioRad Recent Developments

7.2 DexCom

7.2.1 DexCom Profile

7.2.2 DexCom Main Business

7.2.3 DexCom In-vitro Diagnostic Services Products, Services and Solutions

7.2.4 DexCom In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.2.5 DexCom Recent Developments

7.3 Nova Biomedical

7.3.1 Nova Biomedical Profile

7.3.2 Nova Biomedical Main Business

7.3.3 Nova Biomedical In-vitro Diagnostic Services Products, Services and Solutions

7.3.4 Nova Biomedical In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.3.5 OraSure Recent Developments

7.4 OraSure

7.4.1 OraSure Profile

7.4.2 OraSure Main Business

7.4.3 OraSure In-vitro Diagnostic Services Products, Services and Solutions

7.4.4 OraSure In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.4.5 OraSure Recent Developments

7.5 Pearl Pathways

7.5.1 Pearl Pathways Profile

7.5.2 Pearl Pathways Main Business

7.5.3 Pearl Pathways In-vitro Diagnostic Services Products, Services and Solutions

7.5.4 Pearl Pathways In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.5.5 Pearl Pathways Recent Developments

7.6 Phenomenex

7.6.1 Phenomenex Profile

7.6.2 Phenomenex Main Business

7.6.3 Phenomenex In-vitro Diagnostic Services Products, Services and Solutions

7.6.4 Phenomenex In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.6.5 Phenomenex Recent Developments

7.7 Qiagen

7.7.1 Qiagen Profile

7.7.2 Qiagen Main Business

7.7.3 Qiagen In-vitro Diagnostic Services Products, Services and Solutions

7.7.4 Qiagen In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.7.5 Qiagen Recent Developments

7.8 Roche Diagnostics

7.8.1 Roche Diagnostics Profile

7.8.2 Roche Diagnostics Main Business

7.8.3 Roche Diagnostics In-vitro Diagnostic Services Products, Services and Solutions

7.8.4 Roche Diagnostics In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.8.5 Roche Diagnostics Recent Developments

7.9 Siemens

7.9.1 Siemens Profile

7.9.2 Siemens Main Business

7.9.3 Siemens In-vitro Diagnostic Services Products, Services and Solutions

7.9.4 Siemens In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.9.5 Siemens Recent Developments

7.10 Sysmex

7.10.1 Sysmex Profile

7.10.2 Sysmex Main Business

7.10.3 Sysmex In-vitro Diagnostic Services Products, Services and Solutions

7.10.4 Sysmex In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.10.5 Sysmex Recent Developments

7.11 Thermofisher

7.11.1 Thermofisher Profile

7.11.2 Thermofisher Main Business

7.11.3 Thermofisher In-vitro Diagnostic Services Products, Services and Solutions

7.11.4 Thermofisher In-vitro Diagnostic Services Revenue (US$ Million) & (2019-2024)

7.11.5 Thermofisher Recent Developments

8 Industry Chain Analysis

8.1 In-vitro Diagnostic Services Industrial Chain

8.2 In-vitro Diagnostic Services Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 In-vitro Diagnostic Services Sales Model

8.5.2 Sales Channel

8.5.3 In-vitro Diagnostic Services Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Biorad

Dexcom

Nova Biomedical

Orasure

Pearl Pathways

Phenomenex

Qiagen NV

Roche Diagnostics

Siemens AG

Sysmex

ThermoFisher

List of Tables

Table 1. In-vitro Diagnostic Services Market Trends

Table 2. In-vitro Diagnostic Services Market Drivers & Opportunity

Table 3. In-vitro Diagnostic Services Market Challenges

Table 4. In-vitro Diagnostic Services Market Restraints

Table 5. Global In-vitro Diagnostic Services Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global In-vitro Diagnostic Services Revenue Market Share by Company (2019-2024)

Table 7. Key Companies In-vitro Diagnostic Services Manufacturing Base Distribution and Headquarters

Table 8. Key Companies In-vitro Diagnostic Services Product Type

Table 9. Key Companies Time to Begin Mass Production of In-vitro Diagnostic Services

Table 10. Global In-vitro Diagnostic Services Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global In-vitro Diagnostic Services Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global In-vitro Diagnostic Services Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global In-vitro Diagnostic Services Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global In-vitro Diagnostic Services Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global In-vitro Diagnostic Services Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global In-vitro Diagnostic Services Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global In-vitro Diagnostic Services Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global In-vitro Diagnostic Services Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global In-vitro Diagnostic Services Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global In-vitro Diagnostic Services Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global In-vitro Diagnostic Services Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global In-vitro Diagnostic Services Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global In-vitro Diagnostic Services Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global In-vitro Diagnostic Services Sales Value by Region (2019-2024) & (%)

Table 27. Global In-vitro Diagnostic Services Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions In-vitro Diagnostic Services Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions In-vitro Diagnostic Services Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions In-vitro Diagnostic Services Sales Value, (2025-2030) & (US$ Million)

Table 31. BioRad Basic Information List

Table 32. BioRad Description and Business Overview

Table 33. BioRad In-vitro Diagnostic Services Products, Services and Solutions

Table 34. Revenue (US$ Million) in In-vitro Diagnostic Services Business of BioRad (2019-2024)

Table 35. BioRad Recent Developments

Table 36. DexCom Basic Information List

Table 37. DexCom Description and Business Overview

Table 38. DexCom In-vitro Diagnostic Services Products, Services and Solutions

Table 39. Revenue (US$ Million) in In-vitro Diagnostic Services Business of DexCom (2019-2024)

Table 40. DexCom Recent Developments

Table 41. Nova Biomedical Basic Information List

Table 42. Nova Biomedical Description and Business Overview

Table 43. Nova Biomedical In-vitro Diagnostic Services Products, Services and Solutions

Table 44. Revenue (US$ Million) in In-vitro Diagnostic Services Business of Nova Biomedical (2019-2024)

Table 45. Nova Biomedical Recent Developments

Table 46. OraSure Basic Information List

Table 47. OraSure Description and Business Overview

Table 48. OraSure In-vitro Diagnostic Services Products, Services and Solutions

Table 49. Revenue (US$ Million) in In-vitro Diagnostic Services Business of OraSure (2019-2024)

Table 50. OraSure Recent Developments

Table 51. Pearl Pathways Basic Information List

Table 52. Pearl Pathways Description and Business Overview

Table 53. Pearl Pathways In-vitro Diagnostic Services Products, Services and Solutions

Table 54. Revenue (US$ Million) in In-vitro Diagnostic Services Business of Pearl Pathways (2019-2024)

Table 55. Pearl Pathways Recent Developments

Table 56. Phenomenex Basic Information List

Table 57. Phenomenex Description and Business Overview

Table 58. Phenomenex In-vitro Diagnostic Services Products, Services and Solutions

Table 59. Revenue (US$ Million) in In-vitro Diagnostic Services Business of Phenomenex (2019-2024)

Table 60. Phenomenex Recent Developments

Table 61. Qiagen Basic Information List

Table 62. Qiagen Description and Business Overview

Table 63. Qiagen In-vitro Diagnostic Services Products, Services and Solutions

Table 64. Revenue (US$ Million) in In-vitro Diagnostic Services Business of Qiagen (2019-2024)

Table 65. Qiagen Recent Developments

Table 66. Roche Diagnostics Basic Information List

Table 67. Roche Diagnostics Description and Business Overview

Table 68. Roche Diagnostics In-vitro Diagnostic Services Products, Services and Solutions

Table 69. Revenue (US$ Million) in In-vitro Diagnostic Services Business of Roche Diagnostics (2019-2024)

Table 70. Roche Diagnostics Recent Developments

Table 71. Siemens Basic Information List

Table 72. Siemens Description and Business Overview

Table 73. Siemens In-vitro Diagnostic Services Products, Services and Solutions

Table 74. Revenue (US$ Million) in In-vitro Diagnostic Services Business of Siemens (2019-2024)

Table 75. Siemens Recent Developments

Table 76. Sysmex Basic Information List

Table 77. Sysmex Description and Business Overview

Table 78. Sysmex In-vitro Diagnostic Services Products, Services and Solutions

Table 79. Revenue (US$ Million) in In-vitro Diagnostic Services Business of Sysmex (2019-2024)

Table 80. Sysmex Recent Developments

Table 81. Thermofisher Basic Information List

Table 82. Thermofisher Description and Business Overview

Table 83. Thermofisher In-vitro Diagnostic Services Products, Services and Solutions

Table 84. Revenue (US$ Million) in In-vitro Diagnostic Services Business of Thermofisher (2019-2024)

Table 85. Thermofisher Recent Developments

Table 86. Key Raw Materials Lists

Table 87. Raw Materials Key Suppliers Lists

Table 88. In-vitro Diagnostic Services Downstream Customers

Table 89. In-vitro Diagnostic Services Distributors List

Table 90. Research Programs/Design for This Report

Table 91. Key Data Information from Secondary Sources

Table 92. Key Data Information from Primary Sources

Table 93. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. In-vitro Diagnostic Services Product Picture

Figure 2. Global In-vitro Diagnostic Services Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global In-vitro Diagnostic Services Sales Value (2019-2030) & (US$ Million)

Figure 4. In-vitro Diagnostic Services Report Years Considered

Figure 5. Global In-vitro Diagnostic Services Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by In-vitro Diagnostic Services Revenue in 2023

Figure 7. In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Infectious Testing Picture

Figure 9. Diabetes Testing Picture

Figure 10. Molecular Testing Picture

Figure 11. Tissue Testing Picture

Figure 12. Global In-vitro Diagnostic Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global In-vitro Diagnostic Services Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Hospitals

Figure 15. Product Picture of Point-Of-Care Testing

Figure 16. Product Picture of Laboratories

Figure 17. Product Picture of Academic Institutes

Figure 18. Global In-vitro Diagnostic Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global In-vitro Diagnostic Services Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America In-vitro Diagnostic Services Sales Value (2019-2030) & (US$ Million)

Figure 21. North America In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe In-vitro Diagnostic Services Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific In-vitro Diagnostic Services Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

Figure 26. South America In-vitro Diagnostic Services Sales Value (2019-2030) & (US$ Million)

Figure 27. South America In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa In-vitro Diagnostic Services Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa In-vitro Diagnostic Services Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions In-vitro Diagnostic Services Sales Value (%), (2019-2030)

Figure 31. United States In-vitro Diagnostic Services Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

Figure 33. United States In-vitro Diagnostic Services Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe In-vitro Diagnostic Services Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe In-vitro Diagnostic Services Sales Value by Application (%), 2023 VS 2030

Figure 37. China In-vitro Diagnostic Services Sales Value, (2019-2030) & (US$ Million)

Figure 38. China In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

Figure 39. China In-vitro Diagnostic Services Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan In-vitro Diagnostic Services Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan In-vitro Diagnostic Services Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea In-vitro Diagnostic Services Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea In-vitro Diagnostic Services Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia In-vitro Diagnostic Services Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia In-vitro Diagnostic Services Sales Value by Application (%), 2023 VS 2030

Figure 49. India In-vitro Diagnostic Services Sales Value, (2019-2030) & (US$ Million)

Figure 50. India In-vitro Diagnostic Services Sales Value by Type (%), 2023 VS 2030

Figure 51. India In-vitro Diagnostic Services Sales Value by Application (%), 2023 VS 2030

Figure 52. In-vitro Diagnostic Services Industrial Chain

Figure 53. In-vitro Diagnostic Services Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global IVD Market Research Report 2024

In Vitro Diagnostic IVD Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnostic IVD Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IVD In Vitro Diagnostics Products Market Research Report 2024

Global In Vitro Diagnostics IVDs Medical Device Market Research Report 2025

Global In Vitro Diagnostic IVD Products Market Research Report 2024

In Vitro Diagnostics IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Next Generation IVD Market Research Report 2024

Global Molecular in Vitro Diagnostics Market Research Report 2024

In Vitro Diagnostic Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global In Vitro Diagnostics IVDs Products Contract Manufacturing Market Research Report 2024

Global Home Diagnostics Market Research Report 2024

In Vitro Assays to Diagnose Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnosis IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnostic Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Precision Cancer Tests Market Research Report 2024

In Vitro Diagnostics Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Precision Cancer Diagnostic Tests Market

Infectious Disease Testing Using PCR for IVD Market

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions